Choline Supplement Group for Gestational Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Gestational DiabetesCholine supplement - DietarySupplement
Eligibility
18 - 50
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether choline supplements can help prevent macrosomia (large fetus) in pregnant women with gestational diabetes.

Eligible Conditions
  • Gestational Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: At time of birth

At time of birth
Birthweight
Gene expression of glucose transporters

Trial Safety

Trial Design

2 Treatment Groups

Choline Supplement Group
1 of 2
Placebo Group
1 of 2

Active Control

Non-Treatment Group

60 Total Participants · 2 Treatment Groups

Primary Treatment: Choline Supplement Group · Has Placebo Group · N/A

Choline Supplement Group
DietarySupplement
ActiveComparator Group · 1 Intervention: Choline supplement · Intervention Types: DietarySupplement
Placebo Group
DietarySupplement
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at time of birth

Who is running the clinical trial?

Maimonides Medical CenterLead Sponsor
63 Previous Clinical Trials
14,235 Total Patients Enrolled

Eligibility Criteria

Age 18 - 50 · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References